Private Label Azelaic Acid Body Scrub Manufacturer Low MOQ

The minimum order quantity for a private label azelaic acid body scrub typically starts at 100–250 units through specialty indie-focused co-packers who operate stock or semi-custom scrub bases. At this entry tier you are usually choosing from a manufacturer's existing base formula and customizing the label, fragrance, and sometimes the exfoliant particle, rather than developing a fully proprietary recipe from scratch. MOQ rises to 500–1,000 units when you want semi-custom work — swapping in a specific azelaic acid percentage, adding a botanical like turmeric or niacinamide, or specifying a unique exfoliant such as biodegradable jojoba beads. At fully custom development, most contract manufacturers set a floor of 1,000–2,500 units per SKU because the development cost and lab work only amortize at higher volumes. Several factors can push MOQ up or let you negotiate it down. Packaging drives MOQ hard: a standard stock jar has components sitting in the warehouse already, while a custom airless pump or a bespoke mold requires a separate component MOQ that can be 2–5x the formula MOQ. If you can accept a stock packaging format, your unit minimum will be lower. Fill weight also matters — a manufacturer filling 200 g jars on a semi-automated line can often hit lower unit MOQs than one running 50 g tubes through a high-speed line calibrated for large runs. When you request splits across scent variants — say, a lavender version and an unscented version — most manufacturers count each variant as its own SKU against the MOQ, though some will allow a batch split at 60/40 or 50/50. Always confirm this in writing before signing. Small-batch indie co-packers in the US, UK, and parts of Europe specifically market to founders at the 100–500 unit tier. They often charge a higher per-unit cost ($8–$16 vs. $2.50–$5 at scale) to compensate for the smaller run, but the trade-off is lower financial risk on a market-test quantity. Platforms like AJ Cosmo Labs let you post your MOQ requirement up front so only manufacturers who can meet that threshold respond to your brief, cutting weeks of back-and-forth.

The cost to private label an azelaic acid body scrub spans a wide range depending on formula complexity, MOQ, packaging, and the manufacturer's location. At the lowest tier — 100–250 units with a stock base and simple jar packaging — expect to pay $8–$16 per finished unit before shipping. At a growth run of 500–1,000 units with semi-custom formulation, per-unit costs typically fall to $5–$9. At 2,500+ units with a fully developed proprietary formula, well-run manufacturers in the US and EU quote $2.50–$5 per unit. Beyond the unit cost there are one-time or project-level costs you need to budget for. Formula development fees at reputable manufacturers range from $500 to $2,500 depending on the level of customization; some waive this fee if you commit to a production run above their threshold. Stability and challenge testing adds $300–$800 per formula depending on how many preservative systems are evaluated and whether you need accelerated data only or real-time plus accelerated. Safety assessments required for EU or UK market entry cost $400–$1,200 depending on the assessor and the complexity of the INCI list. Packaging is often the largest hidden cost. A stock PET jar may cost $0.30–$0.60 per unit landed, while a custom frosted glass jar with a bamboo lid can cost $1.50–$3.50 per unit and carry its own MOQ of 2,000–5,000 pieces. Label printing for short runs (250–500 labels) on a digital press runs $0.15–$0.50 per label. Cartons and secondary packaging add another $0.20–$0.60 per unit if required for retail. Freight and duties are another variable. A 500-unit order of 200 g scrubs weighs roughly 100–120 kg finished and boxed; domestic US trucking is inexpensive, but air freight from an overseas manufacturer can add $1.50–$3.00 per unit, and ocean freight for smaller consignments (less than a full pallet) often comes with LCL (less-than-container-load) surcharges. A realistic all-in launch budget for a founder ordering 250 units of a private label azelaic acid body scrub — including development, samples, packaging, testing, labels, and freight — is $6,000–$14,000 depending on choices made. AJ Cosmo Labs helps founders compare quotes from multiple vetted cosmetic manufacturers in one place, making it easier to understand the true cost structure before committing to any single supplier.

Finding a low-MOQ cosmetic manufacturer for an active-ingredient scrub like an azelaic acid body scrub requires more targeted searching than a standard moisturizer, because fewer co-packers have validated formulas for acid-active rinse-off products. The general directories and trade-show lists that work for a simple body butter will return a high proportion of manufacturers who either don't work with actives or whose minimum runs are 5,000 units and above. The most reliable starting points are: specialty indie-focused co-packers who explicitly market to small brands (search terms like 'small batch cosmetic manufacturer' or 'indie co-packer body care'), contract development and manufacturing organizations (CDMOs) that advertise active-ingredient expertise on their websites, and curated B2B platforms like AJ Cosmo Labs where manufacturers self-describe their MOQ and active ingredient capabilities before you make contact. When you approach a manufacturer, the first qualification question is whether they have an existing validated formula that contains azelaic acid, or a closely related dicarboxylic acid or hydroxy acid. A manufacturer with experience in salicylic acid toners or glycolic acid scrubs is a much safer bet than one who has only ever made fragrance-only scrubs, because they already understand the pH management, preservative interaction, and stability profile that acids require. Ask for a technical data sheet or formula spec sheet on their existing active-ingredient bases before sending any development deposit. Reputable manufacturers will share this under NDA without hesitation. If they are evasive about sharing basic formulation data even under NDA, move on. Verify GMP certification — ISO 22716 for cosmetics is the global benchmark, and FDA facility registration is essential for US market sales. Check that they can provide a certificate of analysis (COA) and a finished-goods stability report. At the low-MOQ tier, some smaller manufacturers rely on third-party testing labs for these documents rather than running in-house testing; that is acceptable as long as the testing lab is accredited. Geographically, low-MOQ active-ingredient co-packers are concentrated in: the northeastern US, California, the UK (particularly around London and the Midlands), Germany, and South Korea. Korean manufacturers in particular have deep expertise with functional acid formulations and have increasingly opened to Western indie brands, though minimum runs from Korean factories tend to start at 500–1,000 units even for 'low MOQ' offers. Post a detailed brief on AJ Cosmo Labs — including your target azelaic acid percentage, desired exfoliant, fill weight, packaging preference, and MOQ requirement — and let qualified manufacturers come to you rather than cold-contacting dozens of factories one by one.

For a rinse-off body scrub positioned as a cosmetic (not an OTC drug), most cosmetic chemists recommend an azelaic acid concentration between 5% and 10% by weight in the finished formula. This range delivers visible exfoliation and skin-tone benefits during the dwell time of a scrub application (typically 30–90 seconds on skin before rinsing) without crossing into concentrations that regulatory bodies classify as drug-level activity. At 5%, azelaic acid contributes brightening and mild anti-inflammatory activity. Paired with a physical exfoliant like fine sugar or rice bran, the dual-action effect is noticeable to consumers after 4–6 weeks of regular use. At 8–10%, the chemical exfoliation component is more pronounced and the product positions closer to a treatment scrub, which can justify a premium price point but also increases the chance of skin sensitivity in users with reactive skin. Above 10%, you are approaching concentrations used in prescription or OTC drug-category products (azelaic acid is approved as an OTC drug in some markets for acne and rosacea at 15–20%). Making claims about treating acne, rosacea, or post-acne marks at any concentration can trigger drug-classification scrutiny in the US under FDA guidelines and in the EU under the Cosmetics Regulation — so claim language must stay on the cosmetic side regardless of the concentration you choose. The vehicle matters as much as the concentration. Azelaic acid disperses best in formulations with a slightly acidic pH (4.5–5.5), which also happens to be skin-compatible for a body scrub. A cosmetic chemist will typically combine azelaic acid with a humectant base (glycerin, sodium PCA) and a co-emulsifier to keep the acid evenly suspended, particularly if the physical exfoliant particles are dense and prone to sedimentation. Always request stability data from your manufacturer at your chosen concentration. Azelaic acid can yellow slightly under heat stress, which affects the aesthetic of a white or pale-tinted scrub. A preservative system must be chosen that is compatible with the acid environment — some phenoxyethanol-based blends perform better than formaldehyde-releasing preservatives at the pH required for azelaic acid stability. When briefing a manufacturer through AJ Cosmo Labs, specify your target percentage and ask for stability results at 40°C/75% RH (the standard accelerated condition) for at least 8 weeks as part of your sample evaluation criteria.

The baseline certification for any cosmetic contract manufacturer you work with is ISO 22716, the international standard for Good Manufacturing Practice (GMP) in cosmetics. This standard covers personnel, premises, equipment, raw material controls, production, quality control, and document management. A manufacturer who cannot provide an ISO 22716 certificate or a credible third-party audit report against it is a serious risk for any brand selling through retail channels or online marketplaces that conduct supplier audits. For US market sales, FDA facility registration is not legally required for cosmetics manufacturers under current rules (the Modernization of Cosmetics Regulation Act, MoCRA, is phasing in new requirements through 2025–2026 including mandatory facility registration and product listing). However, working with an FDA-registered facility signals a higher level of operational maturity and will increasingly be required as MoCRA rules go into effect. If your body scrub contains any ingredient that could create an OTC drug crossover (like a high azelaic acid percentage with acne-treatment claims), the facility must meet OTC drug manufacturing standards (21 CFR Part 211), which are substantially more demanding. For the EU and UK, the manufacturer itself does not need to be EU-certified, but the product must have a compliant Product Information File (PIF) including a safety assessment by a qualified person. Your EU Responsible Person (RP) — a company or individual based in the EU — is legally accountable for compliance. UK brands need a separate UK Responsible Person post-Brexit. These are administrative and regulatory roles, not factory certifications, but they require specific documentation that your manufacturer must be able to supply. Additional certifications that add commercial value depending on your target market include: COSMOS or Ecocert organic certification (if you want to make natural or organic claims), Leaping Bunny or PETA cruelty-free certification (important for the body care and scrub category where consumers are attuned to animal testing), NSF/ANSI 305 (for personal care products making organic content claims in the US), and Fair Trade certification for brands with ethical sourcing positioning. For packaging, look for manufacturers who can supply PCR (post-consumer recycled) content documentation if you plan to make sustainability claims, as greenwashing enforcement is increasing on both sides of the Atlantic. When evaluating suppliers on AJ Cosmo Labs, you can filter by certification status and review documents on file before initiating contact, which removes the time-consuming step of chasing basic compliance documents from unqualified manufacturers.

The realistic timeline from initial product brief to having finished, shelf-ready private label azelaic acid body scrubs in your hands is 12–20 weeks. The range is wide because timeline is driven primarily by how much formula customization you need, how quickly the manufacturer's production queue opens up, and how fast your packaging and label artwork is finalized. The fastest path — 8–12 weeks — is available to founders who select a manufacturer's existing stock azelaic acid scrub base, choose a stock packaging format (e.g., a standard 200 g PET jar), submit artwork that's print-ready at the outset, and order within a quantity the manufacturer can fill on a single short production run. At this pace, weeks 1–2 are spent on NDA and formula review, weeks 2–4 on sample receipt and approval, weeks 4–6 on label artwork finalization, and weeks 6–12 on production, QC, and shipping. The most common timeline is 14–16 weeks for a semi-custom formulation — where you adjust the exfoliant type, fragrance, or azelaic acid percentage from a base formula — because at least one additional sample round is almost always necessary, adding 2–4 weeks of iteration before formula lock. Fully custom formulation development takes 16–22 weeks or more. Custom development means the manufacturer's cosmetic chemist is building a formula from scratch to your specification, running multiple benchtop iterations, and producing formal stability and safety data before production begins. Stability data alone can take 8–12 weeks of real-time testing if you require it, or 4–6 weeks if you accept accelerated data initially with real-time data following. Common delays and how to avoid them: artwork revisions are the single most frequent cause of timeline slippage — brief a graphic designer early and get manufacturer's packaging template files before the designer starts working. Component lead times are the second most common delay; if your packaging is custom or imported, order components before formula lock to run supply chains in parallel. Regulatory review for EU or UK entry (CPNP notification, safety assessment sign-off) can add 3–6 weeks if not started early. Post your brief on AJ Cosmo Labs as early as possible in your planning process. Founders who enter the platform at the idea stage — before they have artwork or packaging spec locked — consistently reach market faster because they can structure the brief and timeline requirements around what manufacturers can actually deliver, rather than discovering constraints late in the process.

In the United States, azelaic acid used in a rinse-off body scrub at 5–10% concentration is regulated as a cosmetic ingredient under the Federal Food, Drug, and Cosmetic Act (FD&C Act) administered by the FDA, provided the product's label and marketing claims stay within cosmetic boundaries. Cosmetic claims describe how a product affects the appearance of the body — brightening, smoothing, exfoliating, evening skin tone — and do not make therapeutic or disease-treatment claims. The moment a brand makes a claim like 'treats acne,' 'reduces rosacea redness,' or 'clinically proven to clear hyperpigmentation caused by acne,' the product may be regulated as an OTC drug, which triggers substantially higher manufacturing, testing, and labeling requirements under 21 CFR Part 333 or Part 352 depending on the claimed condition. Azelaic acid does not appear on the FDA's approved OTC drug monograph list in the US at cosmetic-level concentrations, but the FDA regulates claims, not just concentrations. This means a 5% azelaic acid scrub sold with acne-treatment claims is treated as a drug, while an identical formula sold as an exfoliating brightening scrub is treated as a cosmetic. The practical implication: work with a regulatory consultant to review all label text, website copy, and social media claims before launch. Under the Modernization of Cosmetics Regulation Act (MoCRA), signed in December 2022, FDA is implementing new rules through 2025–2026 including mandatory facility registration, product listing with FDA, good manufacturing practice regulations for cosmetics, and new substantiation requirements for safety data. Brands and manufacturers must track these rollout dates as they affect both importer and manufacturer obligations. In the European Union, azelaic acid is an approved cosmetic ingredient with no specific restriction listed in Annex II (prohibited substances), Annex III (restricted substances), or Annexes IV–VI (colorants, preservatives, UV filters) of EU Cosmetics Regulation EC 1223/2009. This means it can be used freely at levels justified by the product's safety assessment. However, every cosmetic product placed on the EU market must have a Product Information File (PIF) containing: a cosmetic product safety report signed by a qualified safety assessor, a description of the manufacturing method, a declaration of GMP compliance, and evidence of the claimed effect where any efficacy claim is made. EU claim regulations (EC 655/2013 and the associated technical document) prohibit misleading or exaggerated claims. Terms like 'clinically proven' require supporting clinical or consumer study data that is proportionate to the claim. The Cosmetic Products Notification Portal (CPNP) submission is required before the product is placed on the EU market, handled by your designated EU Responsible Person. For the UK post-Brexit, parallel requirements apply via the UK's Office for Product Safety and Standards (OPSS) portal. The UK maintains its own product notification system and requires a UK Responsible Person. REACH regulation considerations apply if your formula uses substances that are pre-registered under UK REACH, though most cosmetic-grade azelaic acid is already registered. AJ Cosmo Labs connects founders with manufacturers and regulatory consultants who have EU and UK compliance experience, helping you navigate notification requirements without building that expertise in-house from scratch.